Hypoxic preconditioning triggers myocardial angiogenesis: A novel approach to enhance contractile functional reserve in rat with myocardial infarction

Journal of Molecular and Cellular Cardiology

Volumn 34, Issue 3, 2002, Pages 335-348

  Sasaki, Hiroaki ^a   Fukuda, Shoji ^a   Otani, Hajime ^b   Zhu, Li ^a   Yamaura, Genbu ^a   Engelman, Richard M ^c   Das, Dipak K ^a   Maulik, Nilanjana ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b Kansai Medical University   (Japan)

^c BAYSTATE MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Apoptosis; Hypoxic preconditioning; Myocardial infarction; Oxidative stress; VEGF

Indexed keywords

ACTIN; DOBUTAMINE; VASCULOTROPIN; VON WILLEBRAND FACTOR; ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; OXYGEN; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD FLOW; CAPILLARY DENSITY; CONTROLLED STUDY; CORONARY ARTERY COLLATERAL CIRCULATION; CORONARY ARTERY OBSTRUCTION; ENDOTHELIUM CELL; HEART FAILURE; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE PRESSURE; HEART PROTECTION; HYPOXIA; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REOXYGENATION; WESTERN BLOTTING; ANIMAL; ANOXIA; ARTERIOLE; BLOOD; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CAPILLARY; CORONARY ARTERY BLOOD FLOW; CORONARY BLOOD VESSEL; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HEART LEFT VENTRICLE FUNCTION; HEART RATE; METABOLISM; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TIME; VASCULAR ENDOTHELIUM;

ANIMALS; ANOXIA; APOPTOSIS; ARTERIOLES; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BLOTTING, WESTERN; CAPILLARIES; CORONARY CIRCULATION; CORONARY VESSELS; DOBUTAMINE; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; HEART RATE; IN SITU NICK-END LABELING; ISCHEMIC PRECONDITIONING, MYOCARDIAL; LYMPHOKINES; MALE; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; OXYGEN; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 0036513701     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.2001.1516     Document Type: Article

References (32)

1. Starnes S.L., Duncan B.W., Kneebone J.M., Fraga C.H., States S., Rosenthal G.L., Lupinetti F.M. Vascular endothelial growth factor and basic fibroblast growth factor in children with cyanotic congenital heart disease. J Thorac Cardiovasc Surg. 119:2000;534-539.
2. Millauer B., Shawver L.K., Plate K.H., Risau W., Ullrich A. Glioblastoma growth inhibited in vivo by a dominant-negative FLK-1 mutant. Nature (Lond.). 367:1994;576-579.
3. Adamis A.P., Miller M., Bernal M.T., D'Amico D.J., Folkman J., Yeo T.K., Yeo K.T. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol. 118:1994;445-450.
4. Gupta K., Kshirsagar S., Li W., Gui L., Ramakrishnan S., Gupta P., Law P.Y., Hebbel R.P. VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling. Expt Cell Res. 247:1999;495-504.
5. Ferrara N., Davis-Smyth T. The biology of vascular endothelial growth factor. Endocrine Revs. 18:1997;4-25.
6. Huang L.E., Arany Z., Livingston D.M., Bunn H.F. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J Biol Chem. 271:1996;32253-32259.
7. Shima D.T., Adams A.P., Ferrara N., Yeo K.T., Yeo T.K., Allende R., Folkman J., D'Amore P.A. Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen. Mol Med. 1:1995;182-193.
8. Engelman D.T., Watanabe M., Engelman R.M., Rousou J.A., Kisin E., Kagan V.E., Maulik N., Das D.K. Hypoxic preconditioning preserves antioxidant reserve in the working rat heart. Cardiovas Res. 29:1995;133-140.
9. Maulik N., Kagan V.R., Tyurin V.A., Das D.K. Redistribution of phosphatidylethanolamine and phosphatidylserine precedes reperfusion-induced apoptosis. Am J Physiol. 274:1998;H242-H248.
10. Kloner R.A., Bolli R., Marban E., Reinlib L., Braunwald E. Medical and cellular implications of stunning, hibernation, and preconditioning. Circulation. 97:1998;1848-1867.
11. Ray P.S., Estrada-Hernandez T., Sasaki H., Zhu Li, Maulik N. Early effects of hypoxia/reoxygenation on VEGF, Ang-1, Ang-2 and their receptors in the rat myocardium: implications for myocardial angiogenesis. Mol Cell Biochem. 213:2000;145-153.
12. Gozal E., Gozal D. NFκB induction during in vivo hypoxia in dorsocaudal brain stem of rat: effect of MK 801 and L-NAME. J Appl Physiol. 85:1998;372-376.
13. Duerr R.L., Huang S., Miraliakbar H.R., Clark R., Chien K.R., Ross J Jr. Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J Clin Invest. 95:1995;619-627.
14. Ono S., Bhargava V., Ono S., Mao L., Hagan G., Rockman H.A., Ross J Jr. In vivo assessment of left ventricular remodelling after myocardial infarction by digital videocontrast angiography in the rat. Cardiovasc Res. 28:1994;349-357.
15. Xie Z., Gao M., Batra S., Koyama T. The capillary of left ventricular tissue of rats subjected to coronary artery occlusion. Cardiovasc Res. 33:1997;671-676.
16. Leor J., Quinones M.J., Patterson M. Adenovirus-mediated gene transfer into infarcted myocardium: feasibility, timing and location of expression. J Mol Cell Cardiol. 28:1996;2057-2060.
17. ATP channel antagonist, 5-hydroxydecanoate, blocks ischemic preconditioning in the rat heart. J Mol Cell Cardiol. 29:1997;1055-1060.
18. Gumina R.J., Schultz J.E., Yao Z., Kenny D., Warltier D.C., Newman P.J., Gross G.J. Antibody to platelet/endothelial cell adhesion molecule-1 reduces myocardial infarct size in a rat model of ischemia-reperfusion injury. Circulation. 94:1996;3327-3333.
19. McNulty P.H., Darling A., Whiting J.M. Glycogen depletion contributes to ischemic preconditioning in the rat heart in vivo. Am J Physiol. 271:1996;H2283-H2289.
20. Hamburger S.A., Barone F.C., Feuerstein G.Z., Ruffolo RR Jr. Carvedilol reduces infarct size in a canine model of acute myocardial infarction. Pharmacology. 43:1991;113-120.
21. Reinhardt C.P., Dalherg S., Tries M.A., Marcel R., Leppo J.A. Stable labeled microspheres to measure perfusion: validation of a neutron activation assay technique. Am J Physiol. 280:2001;H108-H116.
22. Shizukuda Y., Iwamoto T., Mallet R.T., Downey H.F. Hypoxic preconditioning attenuates stunning caused by repeated coronary artery occlusion in dog heart. Cardiovasc Res. 27:1993;559-564.
23. Lasley R.D., Anderson G.M., Mentzer R.M. Ischemic and hypoxic preconditioning enhance postischemic recovery of function in the rat heart. Cardiovasc Res. 27:1993;565-570.
24. Das D.K. Ischemic preconditioning and myocardial adaptation to ischemia. Cardiovasc Res. 27:1993;2077-2079.
25. Gerber H-P, Dixit V., Ferrara N. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J Biol Chem. 273:1998;13313-13316.
26. Gerber H.P., McMurtrey A., Kowalski J., Yan M., Keyt B.A., Dixit V., Ferrara N. Vascular endothelial growth factor regulates cell survival through the phosphatidylinositol 3′-Kinase/Akt signal transduction pathway. J Biol Chem. 273:46:1998;30336-30343.
27. Nor J.E., Christensen J., Mooney D.J., Polvarini P.J. Vascular endothelial growth factor-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol. 154:1999;375-384.
28. Sasaki H., Ray P.S., Zhu L., Galang N., Maulik N. Oxidative stress due to hypoxia/reoxygenation induces angiogenic factor VEGF in adult rat myocardium: possible role of NFκB. Toxicology. 55:2000;27-35.
29. Li J., Brown L.F., Hibberd M.G., Grossman J.D., Morgan J.P., Simons M. VEGF, Flk-1, and Flt-1 expression in a rat myocardium infarction model of angiogenesis. Am J Physiol. 270:1996;H1803-H1811.
30. Meeson A., Palmer M., Calfon M., Lang R. A relationship between apoptosis and flow during programmed capillary regression is revealed by vital analysis. Develop. 122:1996;3929-3938.
31. Alon T., Hemo I., Itin A., Pe'er J., Stone J., Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med. 1:1995;1024-1028.
32. Shweiki D., Itin A., Soffer C., Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 359:1992;843-845.